| October 1 |
Teva Announces Court of Appeals Denies Novartis' Emergency Motion
on Generic Famvir |
| October 1 |
Eisai Announce Application to Appeal NICE Judicial Review Verdict |
| October 1 |
AstraZeneca Appoints Chief Financial Officer |
| October 1 |
Kissei and Eisai Sign a License Agreement to Develop and
Commercialize Glufast, a Rapid-acting Insulin Secretagogue in China |
| October 1 |
Mitsubishi Tanabe Pharma Corporation Announces Its Establishment |
| October 1 |
Roche Confirms Site Development Plans: Go-Ahead for Office
High-Rise |
| October 1 |
Shire to Support Appeal Against Outcome of Judicial Review of NICE
Guidance Which Denies Newly Diagnosed Patients with Mild
Alzheimer's Disease Access to Drugs on the NHS |
| October 1 |
Bristol-Myers Squibb to Pay More Than $515 Million to Resolve
Allegations of Illegal Drug Marketing and Pricing |
| October 1 |
Mylan Announces Extension of Tender Offers for Its 5.750% Senior
Notes due 2010 and 6.375% Senior Notes due 2015 |
| October 1 |
Amgen Provides Update on Late-Stage and Early-Stage Pipeline at UBS
Global Life Sciences Conference |
| October 1 |
Addex Pharmaceuticals Announces ADX10061 Phase IIa Smoking
Cessation Data |
| October 1 |
Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms
Downsize |
| October 1 |
FivePrime Achieves Target Discovery Milestone With Boehringer
Ingelheim |
| October 1 |
Chemizon Announces Research Collaboration Expansion With Takeda |
| October 1 |
GE and Lilly Announce Research Collaboration to Co-Develop
Molecular In Vitro Diagnostics for Cancer Treatments |
| October 1 |
AmerisourceBergen Acquires Bellco Health for $190 Million |
| October 1 |
PDL BioPharma to Actively Seek Sale of Entire Company or Its Key
Assets |
| October 2 |
Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for
Initiation of Phase 1 Study of ISIS 325568 |
| October 2 |
FDA - MedWatch - Early Communication Issued Regarding Atrial
Fibrillation With Oral And Intravenous Bisphosphonates |
| October 2 |
Isis Announces HSR Approval and Closure of Its Collaboration With
Ortho-McNeil, Inc. |
| October 2 |
Mylan Completes Acquisition of Generics Business of Merck KGaA |
| October 2 |
Mylan Announces Appointment of Didier Barret as President, Europe,
Middle East and Africa |
| October 2 |
Mylan Announces Appointment of John Montgomery as President, Asia
Pacific |
| October 2 |
Mylan Appoints Rajiv Malik as Executive Vice President, Head of
Global Technical Operations |
| October 2 |
Lilly's CEO Calls for Reform of Nation's Drug Safety System |
| October 3 |
Pediatric Asthma Programs With CyDex Captisol Technology Acquired
by AstraZeneca |
| October 3 |
Watson Files Application for Generic FEMCON Fe |
| October 3 |
FDA Sends Letter to Lilly Over Cymbalta Mailer |
| October 3 |
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc.
Announce Completion of Merger |
| October 3 |
Arsenal Capital Announces Sale of Priority Solutions to Thermo
Fisher Scientific |
| October 3 |
Cangene Consolidating R&D Operations |
| October 3 |
FDA Acts to Ensure Thyroid Drugs Don’t Lose Potency Before
Expiration Date |
| October 4 |
More than 40% of US Physicians Report Improved Services from
Pharma, with Merck Rated Highest on Delivering Quality Sales and
Service Experiences |
| October 4 |
Dr. Martin Mackay Named President of Pfizer Global Research and
Development |
| October 4 |
Children's Aching Stomachs: New Research Finds Young Children are
Increasingly Using Medications to Treat Gastrointestinal Ailments |
| October 4 |
Amgen to Postpone Indefinitely Its Plans for a Manufacturing
Facility in Ireland |
| October 4 |
GSK Seeks Prequalification for Cervarix from the World Health
Organization After Obtaining Marketing Approval in Europe |
| October 4 |
Announcement of the Launch of Geninax Tablet, an Oral New-Type
Quinolone Antibacterial Agent, in Japan |
| October 4 |
Novartis Pharmaceuticals Canada Inc. Complies with Request from
Health Canada to Withdraw Prexige (lumiracoxib) in Canada |
| October 4 |
Acorn Acquisition Corp Announces Definitive Agreement to Acquire
Lumen Medical Inc. |
| October 4 |
FDA Announces Initiative to Bolster Generic Drug Program |
| October 4 |
FDA Seeks Nominations for Reagan-Udall Foundation |
| October 4 |
FDA Takes Next Step in Transformation of its Center for Drug
Evaluation and Research |
| October 4 |
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon
with Biojector 2000 |
| October 5 |
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels |
| October 5 |
Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology
Drug Discovery |
| October 5 |
Mylan Settles Its First-to-File Opportunity on Levetiracetam with
UCB |
| October 5 |
Avesthagen-CIPLA JV Acquires State of the Art Biological Company in
Germany |
| October 5 |
Northbank Communications Joins College Hill |
| October 5 |
Navamedic ASA (NO) - Initiates a New Strategic Phase - Navamedic
ASA Completes the Acquisition of Vitaflo Scandinavia AB |
| October 5 |
Aptivus (tipranavir) Capsules Granted Full Approval by the U.S. FDA |
| October 5 |
Merck Wins Product Liability Case in Florida Circuit Court |
| October 8 |
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop
Systemic Antivirals and Antibiotics Based on Boron Chemistry |
| October 8 |
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist
(Formoterol Fumarate) Inhalation Solution is Now Available for
Maintenance Treatment of COPD |
| October 8 |
Shire Divests Non-Core Product Portfolio to Almirall |
| October 8 |
Asuragen Licenses Roche's Real-time Quantitative PCR Technology for
Clinical Gene Expression Profiling |
| October 8 |
GlaxoSmithKline Appoints Andrew Witty CEO Designate |
| October 8 |
Bavarian Nordic Receives USD 50 Million Advance Payment from the
U.S. Government for Fulfilling Contract Milestones |
| October 8 |
Almirall Acquires a Portfolio of Eight Products from Shire Plc for
$213 Million |
| October 8 |
ICC Purchases UK Agency; Strengthens European Presence |
| October 9 |
EPO Rules European Nexium Process Patent Valid |
| October 9 |
NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for
$30 Million to Support Late-Stage Product Development |
| October 9 |
ForSight Labs Announces Acquisition of ForSight Newco II by QLT,
Inc. |
| October 9 |
Biomax Informatics AG Licenses the BioRS Integration and Retrieval
System to Boehringer Ingelheim |
| October 9 |
Lafley Tells Shareholders That 'P&G is Designed to Grow' |
| October 9 |
NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for
$30 Million to Support Late-Stage Product Development |
| October 9 |
Acusphere Statement |
| October 9 |
Global Access Project (GAP) Study Examining Patients' Cancer Care
Experiences Featured in Journal CANCER |
| October 10 |
GlaxoSmithKline and Synta Pharmaceuticals Announce Development and
Commercialization Collaboration for STA-4783 in Oncology |
| October 10 |
Bioenvision and Genzyme File Petition in Delaware Court |
| October 10 |
Health Care Merger and Acquisition Activity Strong in Third Quarter
2007, Year Already Second-Largest Ever in Health Care M&A
According to New Report from Irving Levin Associates, Inc. |
| October 10 |
Medication Shows Promise as a Treatment for Alcohol Dependence |
| October 10 |
DARA BioSciences and Point Therapeutics Announce Merger Plans |
| October 10 |
Thermo Fisher Scientific Acquires Leader in Micro-Volume
Spectrophotometers, NanoDrop Technologies |
| October 10 |
Iowa AG Sues 78 Drug Companies for Overcharging Iowa Medicaid |
| October 10 |
Sales of Etimicin Sulfate to Expand Nationwide as Government
Restriction is Lifted |
| October 10 |
Taisho Revises Earnings Forecasts for FY2007 First Half and Full
Year |
| October 10 |
Lupin Acquires in Japan |
| October 10 |
Delaware Court Approves Bioenvision, Genzyme Joint Petition |
| October 11 |
Karo Bio to Focus its Operations |
| October 11 |
Publicis Groupe Strengthens its Leadership in Digital and
Integrated Healthcare Communications in Italy |
| October 11 |
HER-2 Status Predicts Success of Chemotherapy in Breast Cancer
Treatment, Study Finds |
| October 11 |
Cholesterol-Lowering Drugs Cut Heart Attacks by More Than a Quarter |
| October 11 |
Daiichi-Sankyo to Install Corning Epic System |
| October 11 |
Verispan's Vector One: Higher than Average GERD Market Growth in
Hispanics |
| October 11 |
FDA Advises Cochlear Implant Patients Be Vaccinated |
| October 11 |
Schering-Plough Receives Approval from European Commission for
Planned Acquisition of Organon BioSciences N.V. |
| October 12 |
MAb sector growth will continue to far outstrip that of small
molecules |
| October 12 |
Harvard Bioscience Acquires Panlab s.l. Establishing a Spanish
Subsidiary and Expanding Access in the Neuroscience Research Market |
| October 12 |
Daiichi Sankyo and Forest Laboratories Finalize Contract for
Co-Promotion of Azor |
| October 12 |
PerkinElmer Commences Cash Tender Offer for ViaCell |
| October 12 |
ConsumerLab.com Finds Generic Antidepressant Behaves Differently
from Original Drug May Explain Complaints by Patients |
| October 12 |
Patients Can't Recall Their Medications to Tell Doctors |
| October 12 |
Dong-A Pharmaceutical Co Ltd (000640 Ks) Urges Shareholders to Vote
Against the Kang-Korea Alcohol Nominees at the Oct. 31 EGM |
| October 12 |
Genzyme to Participate in FDA Advisory Committee Meeting on the Use
of Phosphate Binders in Chronic Kidney Disease |
| October 15 |
FDA Removes Partial Hold on Telcyta Clinical Development |
| October 15 |
Pharmacopeia Acquires Selective Androgen Receptor Modulator
('SARM') Program from Bristol-Myers Squibb |
| October 15 |
Pfizer Engages with Nation's Physicians Through Sermo to Improve
Patient Care |
| October 15 |
Orexo to Acquire Biolipox - Building a Specialty Pharma Company
Driven by Innovation |
| October 15 |
Biogen Idec Issues Statement |
| October 15 |
HealthiNation Delivers On Demand Health Programming to Verizon FiOS
TV Subscribers |
| October 15 |
European Medicines Agency Sees Strong Level of Applications in 2007 |
| October 15 |
Biopure Announces Expanded Clinical Program to Target Anemia |
| October 15 |
Sartorius Sells Hydrodynamic Bearings Business to the British
Smiths Group |
| October 15 |
Microarray Sequence Capture Speeds Large-Scale Resequencing of
Targeted Genomic Regions |
| October 15 |
Celera Completes Acquisition of Berkeley HeartLab, Inc. |
| October 15 |
Agendia Acquires Rights to the Discovery of a Major Drug Resistance
Mechanism in Breast Cancer Potentially Leading to a Herceptin
Sensitivity Test |
| October 16 |
Camelot Ventures Sells RealAge to Hearst Magazines |
| October 16 |
Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of
$15.0 Billion Increased 12.7%; EPS was $.88, Including Special
Charges; Excluding Special Charges, EPS was $1.06 * |
| October 16 |
Wyeth to Appeal Nevada Hormone Therapy Trial Verdict |
| October 16 |
Genentech Announces Third Quarter 2007 Results |
| October 16 |
Strong Sales Growth in the First Nine Months of 2007 - Full-year
Outlook and Core Earnings Per Share Target Reaffirmed |
| October 16 |
Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08
Including $0.15 Charge Net of Tax for Licensing Charge |
| October 16 |
Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' -
A Quarterly Review of Scientific Literature on Drugs and Therapies
From April - June 2007 |
| October 16 |
Repros Provides Update for Regulatory Program Associated with
Androxal Development |
| October 16 |
Canon Communications Successfully Launches Medical Design &
Manufacturing (MD&M) Event in Northern California |
| October 16 |
OSI Pharmaceuticals Provides Additional Information About US Sales
of Tarceva |
| October 16 |
Edgeline Holdings to Close on Its Acquisition of Intertech Bio |
| October 16 |
FDA MedWatch: Byetta (exenatide) and Postmarketing Reports of Acute
Pancreatitis |
| October 17 |
Cubist Pharmaceuticals Announces Exclusive Option to Acquire
Illumigen Biosciences |
| October 17 |
ImClone and Bristol-Myers Squibb Announce Joint Agreement With
Merck KGaA to Co-Develop and Co-Commercialize Erbitux in Japan |
| October 17 |
Abbott Reports 14.4 Percent Sales Growth in Third Quarter |
| October 17 |
Allergan Announces Completion of Esprit Pharma Acquisition |
| October 17 |
DARA BioSciences and Bayer Pharmaceuticals Corporation Sign
Exclusive License Agreement |
| October 17 |
Bausch & Lomb Announces Entry Into Agreement to Sell $650
Million of Notes |
| October 17 |
Report Finds Major Gaps Exist in U.S. Pediatric Pandemic
Preparations |
| October 17 |
Drug-Resistant Staph Infection Appears More Widespread Than
Previously Thought |
| October 17 |
ImmunoGen, Inc. Earns Milestone with Start of SAR3419 Clinical
Testing |
| October 18 |
Baxter Reports Strong Third Quarter Sales and Earnings |
| October 18 |
Lilly Delivers Strong Third-Quarter Results |
| October 18 |
Lilly and MacroGenics Announce Licensing and Collaboration
Agreement |
| October 18 |
Wyeth Reports Earnings Results for the 2007 Third Quarter and First
Nine Months |
| October 18 |
Novartis Delivers Record Earnings in First Nine Months of 2007
Thanks to Strong Operational Performance and Divestment Gains |
| October 18 |
Pfizer Reports Third-Quarter 2007 Results; Reconfirms 2007 and 2008
Revenue and Adjusted Diluted EPS Guidance |
| October 18 |
Aspreva to be Acquired by Galenica For US$915 Million |
| October 18 |
IDEX Corporation Acquires Isolation Technologies in a Strategic
Expansion of Its Health and Science Technologies Segment |
| October 18 |
inVentiv Health Provides Sales Teams Contract Update |
| October 18 |
EPO Announces Symbicort European Combination Patent Decision |
| October 18 |
Dong-A Pharmaceutical Co Ltd (000640 KS) Calls on Kang-Korea
Alcohol Nominees at October 31 EGM to Disclose Any Agreements or
Understandings They Have Regarding Their Possible Service as Dong-A
Directors |
| October 19 |
FDA Announces Revisions to Labels for Cialis, Levitra and Viagra |
| October 19 |
Gilead Sciences Announces Third Quarter 2007 Financial Results |
| October 19 |
King Pharmaceuticals Accelerates Strategic Shift to Maximize
Long-Term Growth |
| October 19 |
Nektar Therapeutics Issues Statement on Exubera |
| October 19 |
Dong-A Pharmaceutical Co Ltd (000640 KS) Announces That Glass Lewis
and ISS Governance Services, the Leading Proxy Voting Advisory
Services, Have Recommended Their Clients Vote against Kang-Korea
Alcohol Nominees at the October 31 EGM |
| October 22 |
Thousands of Medical Students Urge Schools to Eliminate
Pharmaceutical Marketing Influence |
| October 22 |
Adenoscan(R) Patent Lawsuits Settled |
| October 22 |
Merck Reports Double-Digit Revenue and Earnings-Per-Share Growth
for Third-Quarter 2007 |
| October 22 |
Avant Immunotherapeutics, Inc. and Celldex Therapeutics, Inc.
Announce Merger Agreement |
| October 22 |
Raptor Pharmaceuticals Acquires Initial Clinical Program
Establishes Subsidiary to Develop Clinical Phase Drugs |
| October 22 |
Schering-Plough Reports Financial Results for Third Quarter of 2007 |
| October 23 |
Biogen Idec Reports Third Quarter 2007 Results |
| October 23 |
Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two
Businesses and Explore Strategic Alternatives with Respect to Its
Generics Business |
| October 23 |
GlaxoSmithKline and Tolerx Form Worldwide Collaboration for
Development and Commercialization of Novel Medication |
| October 23 |
Genzyme Launches Cholestagel in Europe |
| October 23 |
ASCO and ASH Release Updated Guideline on the Use of
Chemotherapy-Related Anemia Treatments in Cancer Patients |
| October 23 |
Update Regarding Clinical Trials of Merck's HIV Vaccine Candidate |
| October 23 |
Statement by Merck & Co., Inc. Regarding FDA Nonprescription
Advisory Committee Review of Mevacor (lovastatin) |
| October 23 |
Two Million Consumers Commit to Healthier Weight-Loss Approach with
alli |
| October 23 |
Delcath Voluntarily Defers Accrual in Clinical Trials |
| October 23 |
Paramount Stockholders Approve Acquisition of Chem Rx |
| October 23 |
Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor
Patent |
| October 23 |
Asuragen Enters Oncology Collaboration with Merck to Develop
Pharmacogenomic Tests |
| October 23 |
Roche Considering Legal Options In Patent Litigation Case |
| October 23 |
Jury Rules Roche Infringes Amgen's EPO Patents |
| October 24 |
Pharmaceutical Advertising Turns to Campaigns Dense with Symbols to
Drive Memorable Advertising for the 2006-2007 TV Season |
| October 24 |
GSK Reports Third Quarter EPS of 23.7p; Significant new Operational
Excellence Programme Announced |
| October 24 |
Q3/2007: Merck Operating Result Rises 56% to EUR 292 Million |
| October 24 |
AAHC Examines Nation's Clinical Trials Infrastructure |
| October 24 |
Med Opportunity Partners Leads Purchase Of St. Louis Based Active
Pharmaceutical Ingredient Manufacturer Reliable Biopharmaceutical
Corporation |
| October 24 |
FDA Sends Sanofi Warning Letter for Ketek Study |
| October 25 |
Bristol-Myers Squibb Company Reports Financial Results for the
Third Quarter and First Nine Months of 2007 |
| October 25 |
FDA and Cephalon Notify Healthcare Professionals of Updates to the
Warnings Section of the Prescribing Information for Provigil
(modafinil) |
| October 25 |
Study Protocols Will be Amended in Two Small Early-Phase Prasugrel
Studies |
| October 25 |
ImClone Systems Reports Third Quarter 2007 Financial Results |
| October 25 |
Shire Launches Clinical Study Results Website |
| October 25 |
Amgen's Third Quarter 2007 Adjusted Earnings Per Share Increased 4
Percent to $1.08 |
| October 25 |
Elan Reports Third Quarter 2007 Financial Results |
| October 25 |
Genzyme and Sunway to Collaborate on Gene Therapy Program in China |
| October 25 |
Novavax and Allergan Terminate Manufacturing Supply Agreement for
Estrasorb |
| October 25 |
Alcon's Third Quarter Sales Rise 11.0 Percent |
| October 25 |
PerkinElmer Announces Expiration of Hart-Scott-Rodino Waiting
Period of Proposed ViaCell Acquisition |
| October 25 |
Barr Confirms Filing an Application With a Paragraph IV
Certification for Patanol Ophthalmic Solution, 0.1% |
| October 25 |
FDA Issues an Early Communication about an Ongoing Safety Review
for Aprotinin Injection (marketed as Trasylol) |
| October 26 |
I-Flow Announces Closing of InfuSystem Transaction |
| October 26 |
NovaBay Pharmaceuticals Prices Initial Public Offering of Common
Stock |
| October 26 |
Kosan to Reacquire Epothilone Program From Roche |
| October 26 |
Pfizer Announces Retirement of Vice Chairman David L. Shedlarz |
| October 26 |
Tapestry Announces Strategy to Focus on TPI 287 Clinical Program |
| October 26 |
Daiichi Sankyo Announces the Revisions of Financial Forecasts for
FY2007 |
| October 26 |
Cortex to Provide Shareholder Update and Host Conference Call on
October 31, 2007 |
| October 26 |
Aviation Upgrade Technologies Enters into Merger Agreement with
OncoVista, Inc. |
| October 26 |
Collexis Holdings Acquires SyynX Solutions, Expands Application
Portfolio |
| October 26 |
Solvay: Nine Months 2007 Results |
| October 26 |
Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center |
| October 26 |
FDA Establishes a Pediatric Review Committee to Consult on General
Review of Pediatric Information Submitted by Sponsors |
| October 26 |
Warburg Pincus Completes Acquisition of Bausch & Lomb |
| October 26 |
Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment
from GlaxoSmithKline |
| October 29 |
Kyowa Hakko Interim Operating Income up 25.2% |
| October 29 |
ChemGenex Announces Strategic Restructuring of Company to Focus on
Late-Stage Cancer Portfolio |
| October 29 |
Takeda Provides Update on Development Status of TAK-475, An
Investigational Compound for Treatment of Hypercholesterolemia |
| October 29 |
AstraZeneca Bolsters Its Worldwide Biologics Division Through
Integration of Cambridge Antibody Technology Into MedImmune |
| October 29 |
Thallion Provides Update on Shigamabs Clinical Development and U.S.
Regulatory Plan |
| October 29 |
John Edwards Introduces Proposals To Stop Misleading Drug Marketing
By Standing Up To Drug Companies |
| October 29 |
Dalton Medicinal Chemistry Partners Achieves Milestone in
Collaboration with Boehringer Ingelheim (Canada) Ltd. |
| October 29 |
Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS |
| October 29 |
CTI Announces the FDA Allows Long Term Use of ISA247 in Isotechnika
Phase 2b Clinical Program for the Prevention of Rejection Following
Kidney Transplantation |
| October 29 |
GAO: Prescription Drugs: FDA Guidance and Regulations Related to
Data on Elderly Persons in Clinical Drug Trials |
| October 29 |
Sen. Grassley Seeks Transparency in FDA Review of Heart Health
Risks with Diabetes Drug |
| October 29 |
Pfizer to Appeal German Court Decision in Lipitor Patent Case;
Company Notes That Ruling Has No Immediate Commercial Impact |
| October 29 |
MedWatch - The FDA Safety Information and Adverse Event Reporting
Program |
| October 29 |
FDA MedWatch: Use of CellCept (mycophenolate mofetil) Associated
with Increased Pregnancy Loss and Congenital Malformations |
| October 30 |
Lilly and Glenmark Pharmaceuticals Announce License Agreement |
| October 30 |
Taisho and Pfizer Sign a Letter of Intent for Taisho's
Schizophrenia Drug Candidate |
| October 30 |
Teva Reports Third Quarter 2007 Results |
| October 30 |
Bradley Pharmaceuticals Announces Definitive Merger Agreement with
Nycomed for $20 Per Share in Cash |
| October 30 |
Pharmos Restructures Operations in Israel |
| October 30 |
Sepracor Inc. Announces Third Quarter 2007 Results and Planned
Reduction in Operating Expenses for 2008 |
| October 30 |
Roche Extends Tender Offer for Ventana |
| October 30 |
Coley Pharmaceutical Group and Pfizer Nominate Additional
Anti-Cancer Compound for Clinical Development |
| October 30 |
Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS |
| October 30 |
P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth |
| October 30 |
Coco-Cola, Kellogg’s, Mattel and Takeda Pharmaceuticals Top
the List of International Brands Guilty of Abusing Consumer Rights. |
| October 30 |
Neurobiological Technologies Announces Pricing of Its $60 Million
Common Stock Offering |
| October 30 |
Minnesota Hormone Therapy Lawsuit Dismissed |
| October 30 |
Chiltern Announces Acquisition of an Independent USA Based Clinical
Research Organization, Clinical Trial Management Services, Inc. |
| October 30 |
Younger Adults Increasingly Treated for Heart Disease-related
Conditions |
| October 30 |
Phase Forward Acquires Green Mountain Logic, An Innovative Provider
of Software for Managing Phase I Clinical Trials |
| October 30 |
Genentech: Open Letter |
| October 31 |
Financial statement for the period 1 January 2007 to 30 September
2007 |
| October 31 |
Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA
Foreign Drug Inspection Program Before House Subcommittee on
Oversight & Investigations |
| October 31 |
Entelos Raises $1.5 m from Pfizer Share Purchase |
